Try it
Pharmacology · Cardiovascular: trimetazidine
Sample itemTrimetazidine is added for a patient with chronic stable angina whose heart rate and blood pressure are already low. How does it act?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Inhibits fatty acid beta-oxidation, shifting myocardium to more oxygen-efficient glucose use
Trimetazidine inhibits 3-ketoacyl-CoA thiolase and so partially inhibits fatty acid oxidation, improving ATP yield per oxygen consumed without haemodynamic effects. Ivabradine, by contrast, lowers heart rate via the funny current.
Option by option
A. Inhibits fatty acid beta-oxidation, shifting myocardium to more oxygen-efficient glucose use (correct)
Correct. It is a metabolic modulator.
B. Blocks cardiac sodium channels
Sodium channel blockade is a feature of ranolazine's late current action, not trimetazidine.
C. Reduces heart rate through the funny current
Funny current inhibition is the action of ivabradine.
D. Dilates coronary arteries via nitric oxide
Nitrate-like vasodilation describes nitrates and nicorandil.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?